Clinical Trial Update: A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating injection of TQB6411 in subjects with advanced malignant tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TQB6411

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Advanced Malignant Tumors | Phase 1 | Status: RECRUITING